NANETS consensus guidelines for the diagnosis of neuroendocrine tumor

AI Vinik, EA Woltering, RRP Warner, M Caplin… - Pancreas, 2010 - journals.lww.com
AI Vinik, EA Woltering, RRP Warner, M Caplin, TM O'Dorisio, GA Wiseman, D Coppola…
Pancreas, 2010journals.lww.com
Neuroendocrine tumors (NETs) are rare, slow-growing neo-plasms characterized by their
ability to store and secrete different peptides and neuroamines. 1 Some of these substances
cause specific clinical syndromes, 2 whereas other may have elevated plasma or urine
levels that are not associated with specific syndromes or symptom complexes Unfortunately,
there is no Bideal neuroendocrine tumor marker,[3 but according to the presentation, the
sensitivity and specificity of each marker vary, and it is generally possible to choose those of …
Neuroendocrine tumors (NETs) are rare, slow-growing neo-plasms characterized by their ability to store and secrete different peptides and neuroamines. 1 Some of these substances cause specific clinical syndromes, 2 whereas other may have elevated plasma or urine levels that are not associated with specific syndromes or symptom complexes Unfortunately, there is no Bideal neuroendocrine tumor marker,[3 but according to the presentation, the sensitivity and specificity of each marker vary, and it is generally possible to choose those of greatest value for each clinical syndrome.
The biochemical markers are those hormones or amines secreted by the neuroendocrine cells from which these tumors are derived. Some of these are not specific to any tumor, but are produced and secreted by most NETs, whereas other biochemical markers are more specific to the type of tumor and where their quantification can lead to the suspicion or confirmation of the presence of such a tumor.
Lippincott Williams & Wilkins